The survival outcomes of unilateral retinoblastoma in Malaysia.

Q3 Medicine

Medical Journal of Malaysia Pub Date : 2025-03-01

A S Ain-Nasyrah, J Rahmat, S A Ghani, I Shatriah

引用次数: 0

Abstract

Retinoblastoma (RB) is the most common malignant intraocular tumour in children and can present as unilateral or bilateral disease. Unilateral RB represents 60% of all cases and tend to present at a relatively advanced stage of RB. Unilateral RB in Malaysia has a one-year survival rate of 99.0% and five-year survival of 93.0%. Shorter lag time, longer duration of follow-up and compliance with follow-up are good prognostic factors for the survival of unilateral RB patients. It is essential to report the prognostic factors associated with unilateral RB in our population. This information will assist healthcare professionals in understanding the factors that influence outcomes and support the development of long-term treatment guideline.

本刊更多论文

马来西亚单侧视网膜母细胞瘤的生存结局。

视网膜母细胞瘤是儿童最常见的恶性眼内肿瘤，可表现为单侧或双侧疾病。单侧RB占所有病例的60%，往往出现在RB的相对晚期。马来西亚单侧RB的1年生存率为99.0%，5年生存率为93.0%。较短的滞后时间、较长的随访时间和随访依从性是单侧RB患者生存的良好预后因素。在我们的人群中报告与单侧RB相关的预后因素是必要的。这些信息将帮助医疗保健专业人员了解影响结果的因素，并支持长期治疗指南的制定。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical Journal of Malaysia Medicine-Medicine (all)

CiteScore

1.20

自引率

0.00%

发文量

165

期刊介绍： Published since 1890 this journal originated as the Journal of the Straits Medical Association. With the formation of the Malaysian Medical Association (MMA), the Journal became the official organ, supervised by an editorial board. Some of the early Hon. Editors were Mr. H.M. McGladdery (1960 - 1964), Dr. A.A. Sandosham (1965 - 1977), Prof. Paul C.Y. Chen (1977 - 1987). It is a scientific journal, published quarterly and can be found in medical libraries in many parts of the world. The Journal also enjoys the status of being listed in the Index Medicus, the internationally accepted reference index of medical journals. The editorial columns often reflect the Association''s views and attitudes towards medical problems in the country. The MJM aims to be a peer reviewed scientific journal of the highest quality. We want to ensure that whatever data is published is true and any opinion expressed important to medical science. We believe being Malaysian is our unique niche; our priority will be for scientific knowledge about diseases found in Malaysia and for the practice of medicine in Malaysia. The MJM will archive knowledge about the changing pattern of human diseases and our endeavours to overcome them. It will also document how medicine develops as a profession in the nation. We will communicate and co-operate with other scientific journals in Malaysia. We seek articles that are of educational value to doctors. We will consider all unsolicited articles submitted to the journal and will commission distinguished Malaysians to write relevant review articles. We want to help doctors make better decisions and be good at judging the value of scientific data. We want to help doctors write better, to be articulate and precise.